Single-cell transcriptomic analysis reveals disparate effector differentiation pathways in human T<sub>reg</sub> compartment.

Luo, Yuechen; Xu, Changlu; Wang, Bing; Niu, Qing; Su, Xiuhua; Bai, Yingnan; Zhu, Shuxian; Zhao, Chunxiao et al. · Nat Commun · 2021

basic_science · Level V

Where this comes from

Abstract

Human FOXP3<sup>+</sup> regulatory T (T<sub>reg</sub>) cells are central to immune tolerance. However, their heterogeneity and differentiation remain incompletely understood. Here we use single-cell RNA and T cell receptor sequencing to resolve T<sub>reg</sub> cells from healthy individuals and patients with or without acute graft-versus-host disease (aGVHD) who undergo stem cell transplantation. These analyses, combined with functional assays, separate T<sub>reg</sub> cells into naïve, activated, and effector stages, and resolve the HLA-DR<sup>hi</sup>, LIMS1<sup>hi</sup>, highly suppressive FOXP3<sup>hi</sup>, and highly proliferative MKI67<sup>hi</sup> effector subsets. Trajectory analysis assembles T<sub>reg</sub> subsets into two differentiation paths (I/II) with distinctive phenotypic and functional programs, ending with the FOXP3<sup>hi</sup> and MKI67<sup>hi</sup> subsets, respectively. Transcription factors FOXP3 and SUB1 contribute to some Path I and Path II phenotypes, respectively. These FOXP3<sup>hi</sup> and MKI67<sup>hi</sup> subsets and two differentiation pathways are conserved in transplanted patients, despite having functional and migratory impairments under aGVHD. These findings expand the understanding of T<sub>reg</sub> cell heterogeneity and differentiation and provide a single-cell atlas for the dissection of T<sub>reg</sub> complexity in health and disease.

Medical subject headings